Differin Gel
- Name:
Differin Gel
- Company:
Galderma International S.A.S. c/o Galderma (U.K) Ltd.
- Active Ingredients:
- Legal Category:
Product subject to medical prescription which may be renewed (B)
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 12/06/20

Click on this link to Download PDF directly
Galderma International S.A.S. c/o Galderma (U.K) Ltd.
 Ltd.jpg)
Company Products
Medicine Name | Active Ingredients |
---|---|
Medicine Name Acnecide Gel 5% | Active Ingredients Benzoyl Peroxide, hydrous |
Medicine Name Azzalure | Active Ingredients Botulinum Toxin Type A |
Medicine Name Curanail 5% w/v Medicated Nail Lacquer | Active Ingredients Amorolfine Hydrochloride |
Medicine Name Differin Cream 0.1% w/w | Active Ingredients Adapalene |
Medicine Name Differin Gel | Active Ingredients Adapalene |
Medicine Name Efracea capsules | Active Ingredients Doxycycline monohydrate |
Medicine Name Epiduo 0.1%/2.5% Gel | Active Ingredients Adapalene, Benzoyl Peroxide |
Medicine Name Etrivex 500 micrograms/g Shampoo | Active Ingredients Clobetasol Propionate |
Medicine Name Loceryl Nail Lacquer | Active Ingredients Amorolfine Hydrochloride |
Medicine Name Metvix Cream | Active Ingredients Methyl Aminolevulinate Hydrochloride |
Medicine Name Mirvaso 3mg/g Gel | Active Ingredients brimonidine tartrate |
Medicine Name Rozex Cream | Active Ingredients Metronidazole |
Medicine Name Rozex Gel | Active Ingredients Metronidazole |
Medicine Name Silkis Ointment | Active Ingredients Calcitriol |
Medicine Name Soolantra 10 mg/g Cream | Active Ingredients Ivermectin |
Medicine Name Tetralysal 300 Capsules | Active Ingredients Lymecycline |
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 12 June 2020 PIL
Reasons for updating
- Change to section 6 - marketing authorisation holder
- Change to section 6 - marketing authorisation number
Free text change information supplied by the pharmaceutical company
Change to MAH and MA number.
Updated on 9 February 2020 SPC
Reasons for updating
- Change to section 4.8 - Undesirable effects
- Change to section 7 - Marketing authorisation holder
- Change to section 8 - Marketing authorisation number(s)
- Change to section 10 - Date of revision of the text
- File format updated to PDF
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 24 October 2018 PIL
Reasons for updating
- Change to section 2 - pregnancy, breast feeding and fertility
Updated on 24 October 2018 SPC
Reasons for updating
- Change to section 4.3 - Contraindications
- Change to section 4.6 - Pregnancy and lactation
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 7 December 2017 SPC
Reasons for updating
- New SPC for new product
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 7 December 2017 SPC
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to Section 4.8 – Undesirable effects - how to report a side effect
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Section 4.8 - Reorganised ADRs according to SOC
Section 10 - Update revision of text date
Updated on 4 December 2017 PIL
Reasons for updating
- New PIL for new product
Updated on 4 December 2017 PIL
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 4 - possible side effects
- Change to section 6 - date of revision
Updated on 14 November 2014 SPC
Reasons for updating
- Change to section 2 - Qualitative and quantitative composition
- Change to section 4.7 - Effects on ability to drive and use machines
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 6.6 - Special precautions for disposal and other handling
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Updated on 23 October 2014 PIL
Reasons for updating
- Change to warnings or special precautions for use
- Change to side-effects
- Change to information about pregnancy or lactation
- Change to date of revision
- Addition of information on reporting a side effect.
Updated on 13 August 2010 PIL
Reasons for updating
- Change to warnings or special precautions for use
- Change to information about pregnancy or lactation
- Change to dosage and administration
Updated on 22 September 2009 SPC
Reasons for updating
- Change to section 4.6 - Pregnancy and lactation
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Updated on 24 June 2009 PIL
Reasons for updating
- Improved electronic presentation
Updated on 9 April 2009 PIL
Reasons for updating
- Change due to user-testing of patient information
Updated on 6 August 2008 SPC
Reasons for updating
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Change to the date of revision of the text
Updated on 27 May 2008 SPC
Reasons for updating
- Change to section 4.8 - Undesirable effects
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Updated on 1 March 2007 PIL
Reasons for updating
- Change to date of revision
Updated on 1 March 2007 SPC
Reasons for updating
- Change to section 7 - Marketing authorisation holder
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Updated on 28 September 2005 SPC
Reasons for updating
- Change to section 4.6 - Pregnancy and lactation
- Change to section 4.9 - Overdose
- Change to section 5.3 - Preclinical safety data
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 23 May 2005 SPC
Reasons for updating
- Change to section 1 - Name of medicinal product
- Change to section 2 - Qualitative and quantitative composition
- Change to section 3 - Pharmaceutical form
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 9 August 2004 PIL
Reasons for updating
- New PIL for medicines.ie
Updated on 28 May 2004 SPC
Reasons for updating
- Change to section 4.8 - Undesirable effects
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 16 June 2003 SPC
Reasons for updating
- New SPC for medicines.ie
Legal category: Product subject to medical prescription which may be renewed (B)